New Drug Application for LAE002 (afuresertib) Accepted by China’s National Medical Products Administration

SHANGHAI, Aug. 11, 2026 /PRNewswire/ — Laekna (2105.HK) announced today that the New Drug Application (NDA) for LAE002 (afuresertib) has been accepted by the Center for Drug Evaluation (CDE) of...